The Impact of Sorafenib in Combination with Transarterial Chemoembolization on the Outcomes of Intermediate-Stage Hepatocellular Carcinoma

BACKGROUND: We investigated the treatment outcomes and hepatic reserve of transarterial chemoembolization (TACE)-refractory patients with recurrent advanced hepatocellular carcinoma (HCC) treated with TACE plus sorafenib. METHODS: Forty-one patients with intermediate-stage HCC defined as being TACE...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Asian Pac J Cancer Prev
Main Authors: Kaibori, Masaki, Matsushima, Hideyuki, Ishizaki, Morihiko, Kosaka, Hisashi, Matsui, Kosuke, Kariya, Shuji, Yoshii, Kengo, Sekimoto, Mitsugu
Formato: Artigo
Idioma:Inglês
Publicado em: West Asia Organization for Cancer Prevention 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8325117/
https://ncbi.nlm.nih.gov/pubmed/33906315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2021.22.4.1217
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados